(Q44061478)

29 November 2017

Synthesis of analogs of L-valacyclovir and determination of their substrate activity for the oligopeptide transporter in Caco-2 cells (English)

1 reference

29 November 2017

0 references

1 reference

Gerda Marie Friedrichsen

1

1 reference

29 November 2017

Weiqing Chen

2

1 reference

29 November 2017

Mikael Begtrup

3

1 reference

29 November 2017

Chao-Pin Lee

4

1 reference

29 November 2017

Philip L Smith

5

1 reference

29 November 2017

Ronald T Borchardt

6

1 reference

29 November 2017

language of work or name

English

0 references

publication date

1 July 2002

1 reference

European Journal of Pharmaceutical Sciences

29 November 2017

1 reference

29 November 2017

16

1 reference

29 November 2017

1-13

1 reference

29 November 2017

1-2

1 reference

The oligopeptide transporter (Pept-1) in human intestine: biology and function

29 November 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0928-0987%2802%2900047-7

7 January 2021

How to Make Drugs Orally Active: A Substrate Template for Peptide Transporter PepT1

1 reference

https://api.crossref.org/works/10.1016%2FS0928-0987%2802%2900047-7

7 January 2021

Modifications on the heterocyclic base of acyclovir: syntheses and antiviral properties

1 reference

https://api.crossref.org/works/10.1016%2FS0928-0987%2802%2900047-7

7 January 2021

Valacyclovir: a substrate for the intestinal and renal peptide transporters PEPT1 and PEPT2.

1 reference

https://api.crossref.org/works/10.1016%2FS0928-0987%2802%2900047-7

7 January 2021

5'-Amino acid esters of antiviral nucleosides, acyclovir, and AZT are absorbed by the intestinal PEPT1 peptide transporter.

1 reference

https://api.crossref.org/works/10.1016%2FS0928-0987%2802%2900047-7

7 January 2021

Sulfinosine congeners: synthesis and antitumor activity in mice of certain N9-alkylpurines and purine ribonucleosides

1 reference

https://api.crossref.org/works/10.1016%2FS0928-0987%2802%2900047-7

7 January 2021

A convenient synthesis of 9-(2-hydroxyethoxymethyl)guanine(acyclovir) and related compounds

1 reference

https://api.crossref.org/works/10.1016%2FS0928-0987%2802%2900047-7

7 January 2021

Pharmacokinetics of acyclovir after intravenous and oral administration.

1 reference

https://api.crossref.org/works/10.1016%2FS0928-0987%2802%2900047-7

7 January 2021

Na(+)-dependent, active nucleoside transport in mouse spleen lymphocytes, leukemia cells, fibroblasts and macrophages, but not in equivalent human or pig cells; dipyridamole enhances nucleoside salvage by cells with both active and facilitated trans

1 reference

https://api.crossref.org/works/10.1016%2FS0928-0987%2802%2900047-7

7 January 2021

Carrier-mediated intestinal absorption of valacyclovir, the L-valyl ester prodrug of acyclovir: 1. Interactions with peptides, organic anions and organic cations in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0928-0987%2802%2900047-7

7 January 2021

Absolute bioavailability and metabolic disposition of valaciclovir, the L-valyl ester of acyclovir, following oral administration to humans

1 reference

https://api.crossref.org/works/10.1016%2FS0928-0987%2802%2900047-7

7 January 2021

Peptide mimics as substrates for the intestinal peptide transporter.

1 reference

https://api.crossref.org/works/10.1016%2FS0928-0987%2802%2900047-7

7 January 2021

Nucleoside transport in human colonic epithelial cell lines: evidence for two Na+-independent transport systems in T84 and Caco-2 cells

1 reference

https://api.crossref.org/works/10.1016%2FS0928-0987%2802%2900047-7

7 January 2021

10.1016/S0928-0987(02)00047-7

Identifiers

DOI

1 reference

29 November 2017

1 reference